Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Commensal Streptococcus mitis is a unique vector for oral mucosal vaccination.

Daifalla N, Cayabyab MJ, Xie E, Kim HB, Tzipori S, Stashenko P, Duncan M, Campos-Neto A.

Microbes Infect. 2015 Mar;17(3):237-42. doi: 10.1016/j.micinf.2014.11.002. Epub 2014 Dec 15.

2.

Recombinant outer capsid glycoprotein (VP7) of rotavirus expressed in insect cells induces neutralizing antibodies in rabbits.

Khodabandehloo M, Shahrabadi MS, Keyvani H, Bambai B, Sadigh Z.

Iran J Public Health. 2012;41(5):73-84. Epub 2012 May 31.

3.

Novel triacsin C analogs as potential antivirals against rotavirus infections.

Kim Y, George D, Prior AM, Prasain K, Hao S, Le DD, Hua DH, Chang KO.

Eur J Med Chem. 2012 Apr;50:311-8. doi: 10.1016/j.ejmech.2012.02.010. Epub 2012 Feb 11.

4.
5.

Inadequately treated wastewater as a source of human enteric viruses in the environment.

Okoh AI, Sibanda T, Gusha SS.

Int J Environ Res Public Health. 2010 Jun;7(6):2620-37. doi: 10.3390/ijerph7062620. Epub 2010 Jun 14. Review.

6.

Health and economic impact of rotavirus vaccination in GAVI-eligible countries.

Kim SY, Sweet S, Slichter D, Goldie SJ.

BMC Public Health. 2010 May 14;10:253. doi: 10.1186/1471-2458-10-253.

7.
8.

Advances in vaccine technology and their impact on managed care.

McCullers JA, Dunn JD.

P T. 2008 Jan;33(1):35-41.

9.

Cost-effectiveness of Rotavirus vaccination in Vietnam.

Kim SY, Goldie SJ, Salomon JA.

BMC Public Health. 2009 Jan 21;9:29. doi: 10.1186/1471-2458-9-29.

10.

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil.

Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, Nakagomi O, Nakagomi T, Dove W, Cunliffe N, Hart CA.

Emerg Infect Dis. 2007 Oct;13(10):1571-3. doi: 10.3201/eid1310.070412.

Supplemental Content

Support Center